 |
PDBsum entry 4m2k
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Angew Chem Int Ed Engl
53:1943-1948
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Biosynthesis of streptolidine involved two unexpected intermediates produced by a dihydroxylase and a cyclase through unusual mechanisms.
|
|
C.Y.Chang,
S.Y.Lyu,
Y.C.Liu,
N.S.Hsu,
C.C.Wu,
C.F.Tang,
K.H.Lin,
J.Y.Ho,
C.J.Wu,
M.D.Tsai,
T.L.Li.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Streptothricin-F (STT-F), one of the early-discovered antibiotics, consists of
three components, a β-lysine homopolymer, an aminosugar D-gulosamine, and an
unusual bicyclic streptolidine. The biosynthesis of streptolidine is a
long-lasting but unresolved puzzle. Herein, a combination of
genetic/biochemical/structural approaches was used to unravel this problem. The
STT gene cluster was first sequenced from a Streptomyces variant BCRC 12163,
wherein two gene products OrfP and OrfR were characterized in vitro to be a
dihydroxylase and a cyclase, respectively. Thirteen high-resolution crystal
structures for both enzymes in different reaction intermediate states were
snapshotted to help elucidate their catalytic mechanisms. OrfP catalyzes an
Fe(II) -dependent double hydroxylation reaction converting L-Arg into
(3R,4R)-(OH)2 -L-Arg via (3S)-OH-L-Arg, while OrfR catalyzes an unusual
PLP-dependent elimination/addition reaction cyclizing (3R,4R)-(OH)2 -L-Arg to
the six-membered (4R)-OH-capreomycidine. The biosynthetic mystery finally comes
to light as the latter product was incorporation into STT-F by a feeding
experiment.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |